SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Evotec and Bristol Myers Squibb Advance Partnership With Second IND Acceptance

The companies reported a second investigational new drug application acceptance in their protein degradation partnership.

BMY

Related stories